Abstract:ABSRACT Ethnopharmacological relevance Traditional Chinese herbal medicine has unique advantages as anti-cancer drugs and adjuvant therapies. Rabdosia rubescens (Hemsl.) H. Hara ( R. rubescens ) is a traditional medicinal plant known for its anti-inflammatory, antioxidant, antibacterial, anti-angiogenic and antitumor properties. The antitumor activity of R. rubescens is widely recognized among the folk communities in Henan Province, China. Aim of the study This study reviews the botany, ethnopharmacology, phytochemistry, anti-tumor active ingredients, mechanisms, and clinical applications of R. rubescens , aiming to provide a comprehensive understanding for its use as an anti-cancer drug and adjuvant therapy. Materials and methods We systematically searched the literature in PubMed, Web of Science, and CNKI using the following keywords: "Rabdosia rubescens," "Isodon rubescens," "traditional application," "anti-tumor," "phytochemistry," "anti-tumor active compounds," "oridonin," and "clinical application." The search covered publications from 1997 to 2024. Inclusion criteria included original studies or reviews focusing on the anti-tumor properties of R. rubescens or its active components. Exclusion criteria included studies related to non-R. rubescens applications. Results R. rubescens is a perennial herbaceous plant in the Lamiaceae family, mainly found in central and southern China. Historically, it has been used to treat conditions such as sore throat, cough, and excess phlegm. The plant contains various compounds, including diterpenes, triterpenes, steroids, flavonoids, phenolic acids, essential oils, amino acids, alkaloids, and polysaccharides, with diterpenes, triterpenes, flavonoids, and phenolic acids being the most active. This review identifies 50 compounds with anti-tumor properties, comprising 34 diterpenes, 2 triterpenes, 7 flavonoids, and 7 phenolic acids. Notably, besides oridonin and ponicidin, the ent-kaurane diterpenoids (20S)-11β,14β,20-trihydroxy-7α,20-epoxy-ent-kaur-16-en15-one and (20S)-11β,14β-dihydroxy-20-ethoxy7α,20-epoxy-ent-kaur-16-en-15-one demonstrate significant anti-tumor activity, attributed to their carbonyl group at C-15, hydroxyl group at C-1, and OEt group at C-20. Mechanistically, R. rubescens combats tumors by blocking the tumor cell cycle, promoting apoptosis, inhibiting cell migration and angiogenesis, inducing ferroptosis, reversing drug resistance, and enhancing radiosensitivity in tumor cells. Clinically, R. rubescens is available in various forms, including tablets, drops, syrups, capsules, and lozenges, and is primarily used for tonsillitis, pharyngitis, and stomatitis. According to the 2020 edition of the Pharmacopoeia of China, R. rubescens tablets are recognized as an adjuvant therapy for cancer. Clinical studies indicate that R. rubescens syrup, tablets, and thermal therapy can enhance cancer patient survival rates and lower tumor recurrence rates. Conclusions Given its traditional and modern uses, active anti-tumor components, and mechanisms, R. rubescens is a promising resource in traditional Chinese medicine for anti-tumor therapy. To realize its full potential, future research should explore additional active anti-tumor compounds beyond oridonin and ponicidin. For these key components, studies should focus on structural modifications to identify new active molecules and essential anti-tumor structures. Clinically, it is important to investigate how R. rubescens interacts with other Chinese herbs in anti-tumor formulations to enhance treatment efficacy and guide appropriate clinical use. Furthermore, future studies should undergo ethical review and include larger-scale randomized controlled trials to validate the efficacy of R. rubescens in treating tumors, thereby promoting its role as an anti-tumor traditional Chinese medicine.

Cytotoxic and Antitumor Agents from Genus Rubia

Research Progress of Rubia Cordifolia L.

Rubus chingii Hu: A Review of the Phytochemistry and Pharmacology

Study on the Chemical Constituents and Anticancer Activity from the Roots of Rubia Cordifolia L.

Antitumor Cyclic Hexapeptides from Rubia Plants: History, Chemistry, and Mechanism (2005–2011)

Quinone Derivatives from the Genus Rubia and Their Bioactivities

Chemical constituents of Rubia tibetica Hook. f. from Tibetan medicine and cytotoxic activity evaluation

A comprehensive review of Rubia cordifolia L.: Traditional uses, phytochemistry, pharmacological activities, and clinical applications

A Review of the Botany, Phytochemistry, Pharmacology and Toxicology of Rubiae Radix et Rhizoma

[Chemical Constituents from Roots and Rhizomes of Rubia Oncotricha and Their Cytotoxic Activities].

Integrating Morphology, Molecular Phylogeny and Chemotaxonomy for the Most Effective Authentication in Chinese Rubia with Insights into Origin and Distribution of Characteristic Rubiaceae-type Cyclopeptides

Review on Anthraquinones Isolated from Rubiaceae Family

Coagulant Compounds in Rubia Cordifolia L.

A novel flavonoid and other constituents from Rubus rosifolius S.Vidal (Rosaceae)

Three New Triterpenoids from Rubia Schumanniana

Rabdosia rubescens (Hemsl.) H. Hara: A Potent Anti-Tumor Herbal Remedy - Botany, Phytochemistry, and Clinical Breakthroughs

Rubus Occidentalis and its bioactive compounds against cancer: From molecular mechanisms to translational advances

Natural Naphthohydroquinone Dimer Rubioncolin C Exerts Anti-Tumor Activity By Inducing Apoptotic And Autophagic Cell Death And Inhibiting The Nf-Kappa B And Akt/Mtor/P70s6k Pathway In Human Cancer Cells

Identification of terpenoids from Rubus corchorifolius L. f. leaves and their anti-proliferative effects on human cancer cells.

Systematic characterization and quantification of Rubiaceae-type cyclopeptides in 20 Rubia species by ultra performance liquid chromatography tandem mass spectrometry combined with chemometrics.

Anticancer Drugs from Traditional Toxic Chinese Medicines